Cambridge Investment Research Advisors, Inc. Neogenomics Inc Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$30.49 - $48.49 $140,772 - $223,878	-4,617 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$41.66 - $52.52 $7,415 - $9,348	178 Added 4.01%	4,617 $222,000
Q2 2021 Aug 10, 2021	SELL	$36.62 - $51.69 $185,370 - $261,654	-5,062 Reduced 53.28%	4,439 $200,000
Q1 2021 May 07, 2021	SELL	$41.56 - $59.88 $30,131 - $43,413	-725 Reduced 7.09%	9,501 $458,000
Q4 2020 Feb 04, 2021	BUY	$36.08 - $56.47 $88,540 - $138,577	2,454 Added 31.57%	10,226 $550,000
Q3 2020 Oct 29, 2020	BUY	$33.26 - $40.48 $12,405 - $15,099	373 Added 5.04%	7,772 $286,000
Q2 2020 Jul 27, 2020	SELL	$24.21 - $31.02 $49,122 - $62,939	-2,029 Reduced 21.52%	7,399 $229,000
Q1 2020 May 08, 2020	SELL	$20.5 - $34.53 $161,929 - $272,752	-7,899 Reduced 45.59%	9,428 $260,000
Q4 2019 Feb 04, 2020	BUY	$18.96 - $29.84 $41,560 - $65,409	2,192 Added 14.48%	17,327 $506,000
Q3 2019 Nov 06, 2019	BUY	$19.12 - $26.24 $97,416 - $133,692	5,095 Added 50.75%	15,135 $289,000
Q2 2019 Aug 15, 2019	SELL	$19.57 - $24.1 $44,384 - $54,658	-2,268 Reduced 18.43%	10,040 $0
Q1 2019 May 08, 2019	BUY	$12.14 - $20.46 $149,419 - $251,821	12,308 New	12,308 $0
Q3 2017 Nov 07, 2017	SELL	$9.11 - $11.26 $119,340 - $147,506	-13,100 Closed	0 $0
Q2 2017 Aug 08, 2017	BUY	N/A	13,100	13,100 $117,000

Others Institutions Holding NEO

# of Institutions

295

Shares Held

125M

Call Options Held

698K

Put Options Held

120K

Black Rock Inc. New York, NY

19.7M
Shares

$322 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

14M
Shares

$230 Million
0.0% of portfolio
Brown Advisory Inc

6.89M
Shares

$113 Million
0.13% of portfolio
Janus Henderson Group PLC London, X0

6.6M
Shares

$108 Million
0.05% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

6.54M
Shares

$107 Million
0.06% of portfolio

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.06B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account